Mirtazapine use may increase the risk of
hypothyroxinemia in patients
affected by major depressive disorder
Running title: Mirtazapine and
hypothyroxinemia
Ying Zhaoa,b,c #, Na Wangb,c #,
Shi Wu Wend,e,f, Mingcan Li b,c,
Yuan Yuan b,c, Ravi Retnakaran g,h,
Ruiling Zhanga*, Desheng Zhaii*
# Ying Zhao and Na Wang should be considered joint
first author.
* Correspondence to: R. Zhang, Xinxiang Medical University, The Second
Affiliated Hospital, Xinxiang 453002, China. zhangruilingxx@163.com
* Correspondence to: D. Zhai, School of Public Health, Xinxiang Medical
University, Xinxiang 453003, China. zds@xxmu.edu.cn